GlaxoSmithKline Pharmaceuticals has informed that the Company has received an Order dated 17th February 2026 for period April 2022 to March 2023 from Maharashtra GST authorities, raising a demand for Rs 6,92,76,478 in Maharashtra State.
The above information is a part of company’s filings submitted to BSE.